November 7, 2025 - 02:43

Former President Donald Trump has made headlines by pledging to reduce the cost of the diabetes medication Ozempic to just $150. This announcement has garnered support from various quarters, including entrepreneur Mark Cuban, who has long been an advocate for affordable healthcare. Cuban remarked that Trump’s initiative aligns with his own mission through Cost Plus Drugs, where he emphasizes transparency in pricing for consumers.
Cuban highlighted the importance of making essential medications more accessible to the public, particularly for those who rely on them for managing chronic conditions. By lowering the price of Ozempic, Trump is addressing a significant concern for many individuals struggling with high healthcare costs. Cuban’s Cost Plus model aims to eliminate the hidden fees and markups often associated with prescription drugs, ensuring that consumers pay a fair price for their medications.
The collaboration of these two figures, despite their differing political backgrounds, illustrates a shared commitment to improving healthcare affordability and accessibility in the United States.
August 20, 2026 - 22:20
The business case for turning the barn lights back onThe steady disappearance of American farms is no longer just a rural issue, it is a structural problem with consequences that reach into every town that once depended on the local harvest. When a...
August 20, 2026 - 12:38
Essity acquires feminine care business in BrazilSwedish hygiene and health company Essity has signed a deal to buy Kenvue`s feminine care operations in Brazil, a move that brings well-known brands like Carefree, Sempre Livre, and o.b. under its...
August 19, 2026 - 17:09
Beware the Business Owner Without Battle Scars. Here's What Their Perfect Story Is Really Hiding.I have learned to worry more about the business owner who claims a smooth ride than the one who can show you the dents. The person with a few visible wounds has at least been in the fight. The one...
August 19, 2026 - 02:21
Inside Caron Treatment Center’s C-Suite ShakeupAt least five senior leaders have left Caron Treatment Centers in recent weeks, marking a significant shift in the organization`s top leadership. The departures span several key departments,...